Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) clinical trial (NCT07059650). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) clinical trial (NCT07059650). Contact the study team or your healthcare provider for specific answers.

Question 3

How does DZD8586 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) clinical trial (NCT07059650). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) clinical trial (NCT07059650). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) clinical trial (NCT07059650). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) clinical trial (NCT07059650). Contact the study team or your healthcare provider for specific answers.

What this study is about